← All trials
NCT05429697
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 9, 2022
- Primary completion
- Jan 8, 2025
- Completion date
- Jun 8, 2026
- First posted
- Jun 23, 2022
- Last posted
- Sep 27, 2022
- Enrollment
- 128
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- SMT bio Co., Ltd.Lead sponsor
- Yonsei UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.